This inventor holds 1 USPTO granted patent. Top assignee: Xiangbei Welman Pharmaceutical Co., Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Haiyong Wang: Innovator in Medicinal Chemistry
Introduction
Haiyong Wang is a prominent inventor based in Hunan, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of hyperuricemia and gout. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Wang holds a patent for a thiazole-5-carboxylic acid derivative, which is represented by Formula (I). This compound, along with its stereoisomers and pharmaceutically acceptable salts, is designed for use in preparing medicaments aimed at preventing or treating hyperuricemia and gout. The compounds developed by Wang demonstrate good tolerance, safety, and excellent uric acid-lowering activity, making them valuable in the pharmaceutical industry.
Career Highlights
Currently, Haiyong Wang is associated with Xiangbei Welman Pharmaceutical Co., Ltd. His role in the company allows him to further his research and development efforts in the pharmaceutical sector. Wang's commitment to innovation is evident in his work, which focuses on creating effective treatments for common health issues.
Collaborations
Wang collaborates with Mingjie Sun, a fellow researcher, to enhance the scope and impact of their work in medicinal chemistry. Their partnership exemplifies the importance of teamwork in advancing scientific research and developing new therapeutic solutions.
Conclusion
Haiyong Wang is a notable inventor whose work in medicinal chemistry has the potential to significantly impact the treatment of hyperuricemia and gout. His innovative patent and collaboration with colleagues highlight his dedication to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile